128 related articles for article (PubMed ID: 35595078)
21. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
[TBL] [Abstract][Full Text] [Related]
22. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
23. Which is the worst risk factor for the long-term clinical outcome? Comparison of long-term clinical outcomes between antecedent hypertension and diabetes mellitus in South Korean acute myocardial infarction patients after stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Diabetes; 2020 Feb; 12(2):119-133. PubMed ID: 31420948
[TBL] [Abstract][Full Text] [Related]
24. Beta-Blocker and Renin-Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120966
[TBL] [Abstract][Full Text] [Related]
25. Outcomes in prediabetes vs. diabetes in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2021 May; 32(3):211-223. PubMed ID: 33060525
[TBL] [Abstract][Full Text] [Related]
26. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
[TBL] [Abstract][Full Text] [Related]
27. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33478003
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
29. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
[TBL] [Abstract][Full Text] [Related]
30. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1022-1037. PubMed ID: 34962070
[TBL] [Abstract][Full Text] [Related]
31. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular outcomes associated with Ultrathin bioresorbable polymer sirolimus eluting stents versus thin, durable polymer everolimus eluting stents following percutaneous coronary intervention in patients with type 2 diabetes mellitus: A meta-analysis of published studies.
Deng S; Yi X; Tian Z
Medicine (Baltimore); 2020 Dec; 99(52):e23810. PubMed ID: 33350767
[TBL] [Abstract][Full Text] [Related]
33. Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Park JY; Rha SW; Noh YK; Choi BG; Hong JY; Choi JW; Ryu SK; Park SH; Kim YH; Jeong MH
J Interv Cardiol; 2021; 2021():6698582. PubMed ID: 34366721
[TBL] [Abstract][Full Text] [Related]
34. Different Statin Effects of ST-elevation Versus Non-ST-Elevation Acute Myocardial Infarction After Stent Implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Med Sci; 2020 Mar; 359(3):156-167. PubMed ID: 32089157
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction.
Choe JC; Cha KS; Lee JG; Kim J; Shin JY; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Jeong MH;
JACC Cardiovasc Interv; 2020 Jan; 13(1):97-111. PubMed ID: 31918948
[TBL] [Abstract][Full Text] [Related]
36. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
37. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Hur SH; Kim IC; Won KB; Cho YK; Yoon HJ; Nam CW; Kim KB; Kim MS; Park J; Rha SW; Chae SC; Kim YJ; Kim CJ; Cho MC; Jeong MH; Ahn YK; Kim HS; Ahn TH; Seung KB; Jang Y; Yoon JH; Seong IW; Hong TJ; Bae JH; Park SJ;
Clin Cardiol; 2016 May; 39(5):276-84. PubMed ID: 27028303
[TBL] [Abstract][Full Text] [Related]
38. Monotherapy versus combination therapy of statin and renin-angiotensin system inhibitor in ST-segment elevation myocardial infarction.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2022; 29(1):93-104. PubMed ID: 32207841
[TBL] [Abstract][Full Text] [Related]
39. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
40. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
